PhaseBio Pharmaceuticals (PHAS) Upgraded at Zacks Investment Research

Retrieved on: 2019-05-28 19:05:14

Tags for this article:

Click the tags to see associated articles and topics

PhaseBio Pharmaceuticals (PHAS) Upgraded at Zacks Investment Research. View article details on hiswai:

Excerpt

<div><b>Schonfeld Strategic Advisors</b> LLC bought a new position in PhaseBio Pharmaceuticals in the 1st quarter valued at $600,000. Wellington Management ...</div>

Article found on:

View Original Article